Two Sigma Securities’s Allena Pharmaceuticals ALNA Stock Holding History

Two Sigma Securities’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-357,044	Closed	-$68K	–	3296
2022 Q2	$68K	Buy	+357,044	New	+$55.3K	﹤0.01%	1805
2021 Q4	–	Sell	-83,689	Closed	-$76K	–	2198
2021 Q3	$76K	Buy	+83,689	New	+$81.9K	﹤0.01%	1345

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Securities's ALNA Position: Q3 2022 in Review

Two Sigma Securities sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 357,044 shares — an estimated $68K sold.

Two Sigma Securities first reported a position in ALNA in Q3 2021 and held it in 2 quarters. The position peaked at $76K in Q3 2021. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Two Sigma Securities reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Two Sigma Securities sold 357,044 Allena Pharmaceuticals shares in Q3 2022, an estimated $68K.
Two Sigma Securities first reported a position in Allena Pharmaceuticals in Q3 2021 and held it in 2 quarters.
Two Sigma Securities's Allena Pharmaceuticals position peaked at $76K in Q3 2021.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.